Bg pattern

VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

VYEPTI 100 mg concentrate for solution for infusion

VYEPTI 300mg concentrate for solution for infusion

eptinezumab

This medicine is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is VYEPTI and what is it used for
  2. What you need to know before you are given VYEPTI
  3. How to use VYEPTI
  4. Possible side effects
  5. Storage of VYEPTI
  6. Contents of the pack and other information

1. What is VYEPTI and what is it used for

VYEPTI contains the active substance eptinezumab, which blocks the activity of calcitonin gene-related peptide (CGRP), a substance that occurs naturally in the body. People with migraine may have elevated levels of this substance.

VYEPTI is used to prevent migrainein adults who have migraine on at least 4 days per month.

VYEPTI may reduce the number of migraine days and improve your quality of life. You may feel the preventive effect from the day after you receive this medicine.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given VYEPTI

Do not use VYEPTI

  • if you are allergic to eptinezumab or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Tell your doctor or nurse before you are given VYEPTI if you have any disease that affects your heart and blood circulation.

VYEPTI may cause serious allergic reactions. These reactions can occur quickly, even while the medicine is being administered. Tell your doctor immediately if you experience any symptoms of an allergic reaction, such as:

  • difficulty breathing
  • fast or weak pulse or a sudden drop in blood pressure that makes you feel dizzy or faint
  • swelling of the lips or tongue
  • severe itching of the skin or rash

Children and adolescents

VYEPTI is not recommended for children or adolescents under 18 years of age because it has not been studied in this age group.

Other medicines and VYEPTI

Tell your doctor if you are using, have recently used or might use any other medicines.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before you are given this medicine.

It is preferable to avoid the use of VYEPTI during pregnancy, as the effects of this medicine on pregnant women are not known.

It is not known whether VYEPTI passes into breast milk. Your doctor will help you decide whether to stop breastfeeding or stop VYEPTI treatment. If you are breastfeeding or plan to breastfeed, consult your doctor before receiving VYEPTI treatment. You and your doctor must decide whether to breastfeed while receiving VYEPTI treatment.

Driving and using machines

The effect of VYEPTI on the ability to drive and use machines is negligible or non-existent.

VYEPTI contains sorbitol

Sorbitol is a source of fructose. If you have hereditary fructose intolerance (HFI), a rare genetic disorder, you should not receive this medicine. Patients with HFI cannot break down fructose, which can cause serious side effects.

Consult your doctor before receiving this medicine if you have HFI.

VYEPTI contains polysorbate

VYEPTI contains 0.15 mg of polysorbate 80 per ml. Polysorbate can cause allergic reactions. Consult your doctor if you have any known allergies.

3. How to use VYEPTI

Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor again.

VYEPTI is given as an infusion (drip) into a vein. The infusion takes about 30 minutes. A healthcare professional, who will prepare the infusion beforehand, will give you VYEPTI. During and after the infusion, the healthcare professional will monitor you according to standard clinical practice to detect signs of an allergic reaction.

The recommended dose is 100 mg administered every 12 weeks. Some patients may benefit from a dose of 300 mg administered every 12 weeks. Your doctor will decide the right dose for you and how long you should continue treatment.

If you use more VYEPTI than you should

Since the medicine will be given to you by a healthcare professional, it is unlikely that you will receive too much VYEPTI. Tell your doctor if you think this is the case.

If you miss a dose of VYEPTI

If a dose is missed, your doctor will decide when the next dose should be given.

If you have any other questions about the use of this medicine, ask your doctor or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor or nurse immediatelyif you notice any of the following side effects; you may need urgent medical treatment:

Common:may affect up to 1 in 10 people:

  • allergic reactions and other infusion-related reactions

Reactions can occur quickly during the infusion. The symptoms of an allergic reaction are:

  • difficulty breathing
  • fast or weak pulse
  • sudden drop in blood pressure that makes you feel dizzy or faint
  • swelling of the lips or tongue
  • severe itching of the skin or rash

Serious allergic reactions are uncommon (may affect up to 1 in 100 people).

Other symptoms that may occur due to the infusion include respiratory symptoms (such as nasal congestion or runny nose, throat irritation, cough, sneezing, difficulty breathing) and feeling tired. These symptoms are usually not serious and do not last long.

Other side effects may occur with the following frequency:

Common: may affect up to 1 in 10 people:

  • nasal congestion
  • sore throat
  • fatigue

Reporting of side effects

If you experience any side effects, talk to your doctor or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of VYEPTI

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of the month shown.

Store in a refrigerator (between 2°C and 8°C).

Do not freeze or shake.

Keep the vial in the outer packaging to protect it from light.

Once removed from the refrigerator, VYEPTI should be stored at room temperature (below 25°C) in the original package and used within 7 days, or discarded. Do not put VYEPTI back in the refrigerator once it has been removed.

After dilution, the solution can be stored at room temperature (below 25°C) or in a refrigerator between 2°C and 8°C. The diluted infusion solution must be administered within 8 hours.

Do not use this medicine if you notice that the solution has visible particles or is cloudy or discolored.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What is in VYEPTI

  • The active substance is eptinezumab.
  • Each 100 mg vial contains 100 mg of eptinezumab per ml.
  • Each 300 mg vial contains 300 mg of eptinezumab per 3 ml.
  • The other ingredients are sorbitol (E420), L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and water for injections.

Appearance and packaging

VYEPTI concentrate for solution for infusion is a clear or slightly cloudy, colorless or pale yellow-brown solution. Each vial contains concentrate in a clear glass vial with a rubber stopper, aluminum seal, and a manual extraction cap.

VYEPTI 100 mg concentrate is available in packs of 1 and 3 single-use vials.

VYEPTI 300 mg concentrate is available in a pack of 1 single-use vial.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

  • Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

For further information about this medicine, contact the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Lundbeck S.A./N.V.

Tél/Tel: +32 2 535 7979

Lietuva

  • Lundbeck A/S

Tel: +45 36301311 (Denmark)

[email protected]

Text in Bulgarian and English with contact information for a Lundbeck Export A/S office and a phone number

Luxembourg/Luxemburg

Lundbeck S.A.

Tél: +32 2 535 7979

Ceská republika

Lundbeck Ceská republika s.r.o.

Tel: +420 225 275 600

Magyarország

Lundbeck Hungaria Kft.

Tel: +36 1 4369980

Danmark

Lundbeck Pharma A/S

Tlf: +45 4371 4270

Malta

  • Lundbeck A/S

Tel: + 45 36301311

Deutschland

Lundbeck GmbH

Tel: +49 40 23649 0

Nederland

Lundbeck B.V.

Tel: +31 20 697 1901

Eesti

Lundbeck Eesti AS

Tel: + 372 605 9350

Norge

  • Lundbeck AS

Tlf: +47 91 300 800

Ελλáδα

Lundbeck Hellas S.A

Τηλ: +30-210-610 5036

Österreich

Lundbeck Austria GmbH

Tel: +43 1 253 621 6033

España

Lundbeck España S.A.

Tel: +34 93 494 9620

Polska

Lundbeck Poland Sp. z o. o.

Tel.: + 48 22 626 93 00

France

Lundbeck SAS

Tél: + 33 1 79 41 29 00

Portugal

Lundbeck Portugal – Produtos Farmacêuticos,

Unipessoal Lda

Tel: +351 21 00 45 900

Hrvatska

Lundbeck Croatia d.o.o.

Tel.: + 385 1 6448263

România

Lundbeck Romania SRL

Tel: +40 21319 88 26

Ireland

Lundbeck (Ireland) Limited

Tel: +353 1 468 9800

Slovenija

Lundbeck Pharma d.o.o.

Tel.: +386 2 229 4500

Ísland

Vistor hf.

Tel: +354 535 7000

Slovenská republikaa

Lundbeck Slovensko s.r.o.

Tel: +421 2 5341 42 18

Italia

Lundbeck Italia S.p.A.

Tel: +39 02 677 4171

Suomi/Finland

Oy H. Lundbeck Ab

Puh/Tel: +358 2 276 5000

Κúπρος

Lundbeck Hellas A.E

Τηλ: +357 22 48 38 58

Sverige

  • Lundbeck AB

Tel: +46 40 699 8200

Latvija

  • Lundbeck A/S

Tel: +45 36301311 (Denmark)

[email protected]

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: https://www.ema.europa.eu.

This information is intended only for healthcare professionals:

Instructions for dilution and administration.

This medicine must be diluted before administration. The dilution should be prepared by a healthcare professional using aseptic technique to ensure the sterility of the prepared infusion solution.

The medicine does not contain preservatives and is for single use; unused medicine should be discarded.

Before dilution, the medicine (concentrate in the vials) should be inspected visually; do not use if the concentrate has visible particles or is cloudy or discolored (except clear or slightly cloudy, colorless or pale yellow-brown).

For both the 100 mg and 300 mg doses, a 100 ml bag of sodium chloride 9 mg/ml (0.9%) injection solution should be used to prepare the VYEPTI infusion solution as described below. No other diluents or volumes other than those stated should be used to prepare the VYEPTI infusion solution.

Invert the VYEPTI infusion solution gently to mix completely. Do not shake.

After dilution, the VYEPTI infusion solution should be administered within 8 hours.

During this time, the VYEPTI infusion solution can be stored at room temperature (below 25°C) or refrigerated between 2°C and 8°C. If refrigerated, allow the VYEPTI infusion solution to reach room temperature before administration. DO NOT FREEZE.

  • VYEPTI dose of 100 mg

To prepare the VYEPTI infusion solution, withdraw 1.0 ml of VYEPTI from a single-use vial of 100 mg with a sterile needle and syringe. Inject the contents of 1.0 ml (100 mg) into a 100 ml bag of 0.9% sodium chloride injection solution.

  • VYEPTI dose of 300 mg

To prepare the VYEPTI infusion solution, withdraw 1.0 ml of VYEPTI from 3 single-use vials of 100 mg or 3.0 ml of VYEPTI from a single-use vial of 300 mg with a sterile needle and syringe. Inject the resulting 3.0 ml (300 mg) into a 100 ml bag of 0.9% sodium chloride injection solution.

Instructions for infusion administration

Parenteral medicines should be inspected visually for particles and discoloration before administration. If the liquid contains visible particles or is cloudy or discolored, it should not be used.

Administer the VYEPTI dose of 100 mg or 300 mg as prescribed, after diluting the contents of the vial in a 100 ml bag of 0.9% sodium chloride injection solution, over approximately 30 minutes. Use an infusion set with an in-line or additional filter of 0.2 or 0.22 μm. After the infusion is complete, flush the line with 20 ml of 0.9% sodium chloride injection solution.

Do not administer VYEPTI as a bolus injection.

No other medicines should be administered through the same infusion set or mixed with VYEPTI.

Disposal of unused medicine and all materials that have come into contact with it should be done according to local regulations.

Online doctors for VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (30)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION?
VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION is eptinezumab. This information helps identify medicines with the same composition but different brand names.
Who manufactures VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION?
VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION is manufactured by H. Lundbeck A/S. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VYEPTI 100 MG CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (eptinezumab) include AIMOVIG 140 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AIMOVIG 70 mg SOLUTION FOR INJECTION IN A PRE-FILLED PEN, AJOVY 225 mg PRE-FILLED SYRINGE SOLUTION FOR INJECTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media